Financial Statements · Financial Reporting
Advagen Pharma Europe OÜ
Official identifier 16738127Record date 31 Mar 2024
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2023
- Period start
- 15 May 2023
- Submitted date
- 2 May 2025
Report
- Consolidated
- No
- Audited
- No
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 2,226,759 |
| Balance sheet | Cash and cash equivalents | 0 |
| Balance sheet | Current assets | 2,226,759 |
| Balance sheet | Current liabilities | 2,220,044 |
| Balance sheet | Equity | 6,715 |
| Balance sheet | Share capital at nominal value | 0 |
| Income statement scheme 1 | Revenue | 354,702 |
| Income statement scheme 1 | Annual period profit / loss | 6,715 |
| Income statement scheme 1 | Operating profit (loss) | 11,135 |
| Income statement scheme 1 | Profit (loss) before income tax | 6,715 |
| Note: Labour costs | Employees | 0 |
| Note: Labour costs | Labour costs | 0 |
Linked company
Company: Advagen Pharma Europe OÜ